Gilead to get cancer cells drugmaker Immunomedics in $21 billion bargain

0
1
Loading ....

Gilead Sciences will certainly get biotech firm Immunomedics in a $21 billion bargain that will certainly increase Gilead’s schedule of cancer cells therapies, the firms revealed on Sunday..
The bargain will certainly give …
Read More

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here